ORMDL3 and hepatocellular carcinoma: In conclusion, subcutaneous tumor transplantation experiment showed that sorafenib could inhibit the growth of mouse hepatocellular tumors, while silencing HCC cell ORMDL3 could increase the inhibitory effect of sorafenib on the growth of mouse hepatocellular tumors.